China · Delayed Price · Currency is CNY Sailong Pharmaceutical Group Company Description
Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China.
The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding drugs, analgesics, and other fields.
Sailong Pharmaceutical Group Co.,Ltd. was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co.,Ltd. in September 2021.
The company was founded in 2002 and is based in Zhuhai, China.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 514 |
| CEO | Nan Gui Cai |
Contact Details
Address: 21F, Unit 2, No. 31 Zhuhai, 519060 China | |
| Phone | 86 75 6388 2955 |
| Website | sailong.cn |
Stock Details
| Ticker Symbol | 002898 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000032S5 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nan Gui Cai | Chairman and Chief Executive Officer |
| Jian Feng Li | Deputy GM and Director |
| Dawen Liu | Deputy GM and Non-Independent Director |
| Zhang Xu | Board Secretary, Deputy GM and Director |
| Xing Wang | Deputy General Manager |
| Jing Gao | Financial Director |
| Tangneng Qu | Accounting Supervisor |
| Dai Feng Duan | Deputy General Manager |